BioLife Solutions, Inc. (BLFS) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 48.91M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 48.91M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 48.91M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 48.91M | (m) | (m) |
| 2026-03-31 | 48.86M | (m) | (m) |
| 2025-12-31 | 48.90M | (m) | (m) |
| 2025-09-30 | 48.15M | (m) | (m) |
| 2025-06-30 | 47.91M | (m) | (m) |
| 2025-03-31 | 47.56M | (m) | (m) |
| 2024-12-31 | 47.00M | (m) | (m) |
| 2024-09-30 | 46.39M | (m) | (m) |
| 2024-06-30 | 46.14M | (m) | (m) |
| 2024-03-31 | 46.03M | (m) | (m) |
| 2023-12-31 | 45.30M | (m) | (m) |
| 2023-09-30 | 44.03M | (m) | (m) |
| 2023-06-30 | 43.49M | (m) | (m) |
| 2023-03-31 | 43.46M | (m) | (m) |
| 2022-12-31 | 43.21M | (m) | (m) |
| 2022-09-30 | 42.77M | (m) | (m) |
| 2022-06-30 | 42.61M | (m) | (m) |
| 2022-03-31 | 42.41M | (m) | (m) |
| 2021-12-31 | 42.09M | (m) | (m) |
| 2021-09-30 | 41.65M | (m) | (m) |
| 2021-06-30 | 40.70M | (m) | (m) |
| 2021-03-31 | 40.39M | (m) | (m) |
| 2020-12-31 | 33.40M | (m) | (m) |
| 2020-09-30 | 32.74M | (m) | (m) |
| 2020-06-30 | 32.00M | (m) | (m) |
| 2019-12-31 | 24.00M | (m) | (m) |
| 2019-09-30 | 20.45M | (m) | (m) |
| 2019-06-30 | 19.00M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |